Pilot Study of a Prophylactic Neopeptide Vaccine in Advanced ALK+ NSCLC
Conditions:   NSCLC Stage IV;   ALK Fusion Protein Expression Intervention:   Biological: Peptide vaccine Sponsor:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials

Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Condition:   Advanced Malignant Solid Tumors Intervention:   Biological: Neoantigen mRNA Personalised Cancer vaccine Sponsors:   Stemirna Therapeutics;   Peking University Cancer Hospital & Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials

Pilot Study of a Prophylactic Neopeptide Vaccine in Advanced ALK+ NSCLC
Conditions:   NSCLC Stage IV;   ALK Fusion Protein Expression Intervention:   Biological: Peptide vaccine Sponsor:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials

Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Condition:   Advanced Malignant Solid Tumors Intervention:   Biological: Neoantigen mRNA Personalised Cancer vaccine Sponsors:   Stemirna Therapeutics;   Peking University Cancer Hospital & Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials

Pilot Study of a Prophylactic Neopeptide Vaccine in Advanced ALK+ NSCLC
Conditions:   NSCLC Stage IV;   ALK Fusion Protein Expression Intervention:   Biological: Peptide vaccine Sponsor:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials

Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Condition:   Advanced Malignant Solid Tumors Intervention:   Biological: Neoantigen mRNA Personalised Cancer vaccine Sponsors:   Stemirna Therapeutics;   Peking University Cancer Hospital & Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials

Pilot Study of a Prophylactic Neopeptide Vaccine in Advanced ALK+ NSCLC
Conditions:   NSCLC Stage IV;   ALK Fusion Protein Expression Intervention:   Biological: Peptide vaccine Sponsor:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials

Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Condition:   Advanced Malignant Solid Tumors Intervention:   Biological: Neoantigen mRNA Personalised Cancer vaccine Sponsors:   Stemirna Therapeutics;   Peking University Cancer Hospital & Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials

Pilot Study of a Prophylactic Neopeptide Vaccine in Advanced ALK+ NSCLC
Conditions:   NSCLC Stage IV;   ALK Fusion Protein Expression Intervention:   Biological: Peptide vaccine Sponsor:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials

Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Condition:   Advanced Malignant Solid Tumors Intervention:   Biological: Neoantigen mRNA Personalised Cancer vaccine Sponsors:   Stemirna Therapeutics;   Peking University Cancer Hospital & Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials

Pilot Study of a Prophylactic Neopeptide Vaccine in Advanced ALK+ NSCLC
Conditions:   NSCLC Stage IV;   ALK Fusion Protein Expression Intervention:   Biological: Peptide vaccine Sponsor:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials

Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Condition:   Advanced Malignant Solid Tumors Intervention:   Biological: Neoantigen mRNA Personalised Cancer vaccine Sponsors:   Stemirna Therapeutics;   Peking University Cancer Hospital & Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials

Pilot Study of a Prophylactic Neopeptide Vaccine in Advanced ALK+ NSCLC
Conditions:   NSCLC Stage IV;   ALK Fusion Protein Expression Intervention:   Biological: Peptide vaccine Sponsor:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials